Prevalance of BRCA1 and BRCA2 mutations in familial breast cancer patients in Lebanon

被引:0
作者
Nadine Jalkh
Jinane Nassar-Slaba
Eliane Chouery
Nabiha Salem
Nancy Uhrchammer
Lisa Golmard
Domique Stoppa-Lyonnet
Yves-Jean Bignon
André Mégarbané
机构
[1] Université Saint-Joseph,Unité de Génétique Médicale et laboratoire associé INSERM à l’Unité UMR_S910
[2] Centre Jean Perrin,Département d'Oncogénétique
[3] Université Paris-Descartes,Génétique oncologique, Institut Curie
[4] Université Saint-Joseph,Hôpital, Inserm U830
来源
Hereditary Cancer in Clinical Practice | / 10卷
关键词
BRCA1; BRCA2; Breast cancer; Familial; Gene; Lebanon; Mutation;
D O I
暂无
中图分类号
学科分类号
摘要
Breast cancer is the most prevalent malignancy in women in Western countries, currently accounting for one third of all female cancers. Familial aggregation is thought to account for 5–10 % of all BC cases, and germline mutations in BRCA1 and BRCA2 account for less of the half of these inherited cases. In Lebanon, breast cancer represents the principal death-causing malignancy among women, with 50 % of the cases diagnosed before the age of 50 years.
引用
收藏
相关论文
共 50 条
  • [1] Prevalance of BRCA1 and BRCA2 mutations in familial breast cancer patients in Lebanon
    Jalkh, Nadine
    Nassar-Slaba, Jinane
    Chouery, Eliane
    Salem, Nabiha
    Uhrchammer, Nancy
    Golmard, Lisa
    Stoppa-Lyonnet, Domique
    Bignon, Yves-Jean
    Megarbane, Andre
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2012, 10
  • [2] BRCA1 and BRCA2 germline mutations in 85 Iranian breast cancer patients
    Keshavarzi, Fatemeh
    Javadi, Gholam Reza
    Zeinali, Sirous
    FAMILIAL CANCER, 2012, 11 (01) : 57 - 67
  • [3] BRCA1 and BRCA2 germline mutations in Chinese Hakka breast cancer patients
    Zhang, Yinmei
    Wu, Heming
    Gan, Caiyan
    Rao, Hui
    Wang, Qiuming
    Guo, Xueming
    BMC MEDICAL GENOMICS, 2024, 17 (01)
  • [4] BRCA1 and BRCA2 germline mutations in 85 Iranian breast cancer patients
    Fatemeh Keshavarzi
    Gholam Reza Javadi
    Sirous Zeinali
    Familial Cancer, 2012, 11 : 57 - 67
  • [5] Analysis of BRCA1 and BRCA2 Mutations in Southern Iranian Breast Cancer Patients
    Fattahi, Mohammad Javad
    Mojtahedi, Zahra
    Karimaghaee, Nazanin
    Talei, Abdul-Rasoul
    Banani, Seeyed Javad
    Ghaderi, Abbas
    ARCHIVES OF IRANIAN MEDICINE, 2009, 12 (06) : 584 - 587
  • [6] BRCA1 and BRCA2 germline mutations in Chinese Hakka breast cancer patients
    Yinmei Zhang
    Heming Wu
    Caiyan Gan
    Hui Rao
    Qiuming Wang
    Xueming Guo
    BMC Medical Genomics, 17
  • [7] BRCA1 and BRCA2 mutations in Iranian breast cancer patients: A systematic review
    Neamatzadeh, Hossein
    Shiryazdi, Seyed Mostafa
    Kalantar, Seyed Mahdi
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2015, 20 (03): : 284 - 293
  • [8] BRCA1 and BRCA2 mutations among familial breast cancer patients from Costa Rica
    Gutierrez Espeleta, G. A.
    Llacuachaqui, M.
    Garcia-Jimenez, L.
    Aguilar Herrera, M.
    Loaiciga Vega, K.
    Ortiz, A.
    Royer, R.
    Li, S.
    Narod, S. A.
    CLINICAL GENETICS, 2012, 82 (05) : 484 - 488
  • [9] BRCA1 and BRCA2 mutations in breast cancer patients from Venezuela
    Lara, Karlena
    Consigliere, Nigmet
    Perez, Jorge
    Porco, Antonietta
    BIOLOGICAL RESEARCH, 2012, 45 (02) : 117 - 130
  • [10] Breast surveillance of patients with BRCA1 and BRCA2 mutations
    Warner E.
    Current Breast Cancer Reports, 2013, 5 (3) : 255 - 261